BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230612
DTEND;VALUE=DATE:20230614
DTSTAMP:20260516T063430
CREATED:20230323T114637Z
LAST-MODIFIED:20230323T114637Z
UID:36890-1686528000-1686700799@www.pharmajournalist.com
SUMMARY:6th Annual Pre-Filled Syringes West Coast Conference
DESCRIPTION:Assessing Device Development and Regulation for Advanced Innovation\nSponsors: Datwyler\, Haselmeier\, Mitsubishi Gas Chemical\, Nemera\, ZEON \nExhibitors: Credence MedSystems\, Kymanox\, Noble\, Owen Mumford Pharmaceutical Services\, SCHERDEL Medtec \nSAE Media Group’s 7th Annual Pre-Filled Syringes West Coast Conference will be back for 2023 in San Diego to bring together the device developers\, innovative biotech\, and big pharma. \nThis year’s conference will explore the exciting advances in the combination product drug delivery space and a future outlook exploring how pharma\, device developers and regulators can work together to encourage innovation. \nWith the injectable drug delivery industry rapidly advancing year-to-year\, administration using pre-filled syringes\, auto-injectors\, and pen-injectors are increasingly common. Innovations in device technology\, such as connected devices are leading the way in device design in addition to injectable delivery devices for novel and large volume drugs. With the need for self-administration growing\, there is an enhanced demand for on-body injectors and digitalised health as well as patient centricity. We are beginning to see environmental sustainability being incorporated into aspects of device lifecycle from design to manufacturing and the use of the device. This year’s conference looks to address these hot topics through case studies and industry insights. \nAs part of SAE’s leading injectable drug delivery conferences this is a must attend event; not only will the conference bring delegates key insights to enhance their drug device portfolio\, but it will also give them the opportunity to network with key industry players.  \nBenefits of Attending: \n\nEngage with industry representatives about the latest technologies and advances within the injectable device market and directions to take to advance your device portfolio\nGain insight into new technologies for wearable injectors he delivery of novel and large volume drugs\nUnderstand the latest regulatory requirements and guidance to ensure your combination products are compliant such as meeting essential performance requirements\nDelve into aspects of primary packaging such as material components to consider during device design to ensure drug stability and safety\nExplore how digital technologies such as companion apps are being incorporated into drug delivery devices to improve user-centricity\n\nWho should attend: \nDirectors\, Heads of Departments and Managers for the following areas: \n\nDevice Development\nDevice Engineering\nCombination Product Development\nDrug Delivery Devices\nPrimary Packaging Development\nDigital Health\nLarge Volume Drug Delivery\nNovel Drug Product Formulation\nRegulatory Affairs\n\nEarly Bird Rates: \n\nEB1 – 28 Feb 2023 – US$400\nEB2 -31 March 2023 – US$200\nEB3 – 28 April 2023 – US$100\n\nAdditional Contact Info: \nT: +44 (0)20 7827 \nE: Hannah.Blake@saemediagroup.com \nW: http://www.prefilled-syringes-westcoast.com/PharmaJournalist-El
URL:https://www.pharmajournalist.com/event/6th-annual-pre-filled-syringes-west-coast-conference/
LOCATION:San Diego\, CA\, USA
ORGANIZER;CN="SAE Media Group":MAILTO:events@saemediagroup.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230613
DTEND;VALUE=DATE:20230616
DTSTAMP:20260516T063430
CREATED:20230228T084503Z
LAST-MODIFIED:20230228T084623Z
UID:36697-1686614400-1686873599@www.pharmajournalist.com
SUMMARY:3rd Annual Gene Therapy Patient Engagement
DESCRIPTION:As the global healthcare system accelerates its acceptance of gene therapies as one-time\, potentially curative\, treatment options for rare diseases\, the role of patient engagement in informing drug development strategy is evolving. \nAt this interface lies the 3rd Gene Therapy Patient Engagement Summit\, uniting patient advocacy and engagement experts from leading gene therapy and gene editing drug developers\, along with patient groups and patients themselves. Talks\, workshops\, and group discussions will shed a light on how to better integrate the patient voice into gene therapy programs at crucial stages of the drug development process. \nJoin us in Boston this summer to gain the actionable insights\, tools\, and strategies you need to better implement patient input into patient-centric gene therapy programs. \nTo know more visit: https://ter.li/rbofji
URL:https://www.pharmajournalist.com/event/3rd-annual-gene-therapy-patient-engagement/
LOCATION:Westin Boston Seaport\, 425 Summer Street\, Boston\, MA\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230613
DTEND;VALUE=DATE:20230616
DTSTAMP:20260516T063430
CREATED:20230320T154738Z
LAST-MODIFIED:20230320T154738Z
UID:36873-1686614400-1686873599@www.pharmajournalist.com
SUMMARY:Temperature Control and Logistics Summit
DESCRIPTION:Advance your end-to-end logistics strategy to deliver vital therapeutics at the RIGHT TIME\, RIGHT PLACE and the RIGHT TEMPERATURE \nJoin us in Frankfurt in June 2023 in a brand-new venue at the heart of Europe\, as once again\, we return live and in-person for 3 days of interactive sessions\, collaborative roundtables as well as formal and informal networking to maximise the value of shared insights and open discussions. \nWe meet at a time of great challenge and opportunity. How can we mitigate risk and ensure quality whilst adopting the new technologies essential to future success? In what ways can we bolster the resilience of our supply chains without compromising operational agility? How can we build a supply chain and logistics network that is both effective and environmentally sustainability? \nOnly in partnering across the supply chain can we confront these challenges; and as a community that thrives on innovation and collaboration\, we’ve built a programme centred on the fundamental challenges of our time\, including how we: \n>> Drive Digital Transformation Throughout The Supply Chain To Achieve Full End-To-End Visibility\n>>Enhance Supply Chain & Logistics Network Design To Bolster Resilience\, Security & Efficiency\n>> Partner Across The Network To Meet The Demands of An Increasingly Complex Operating Environment\n>> Leverage New Packaging Innovation To Ensure Quality & Demonstrate Regulatory Compliance\n>> Build An Environmentally Sustainability Temperature Controlled Supply Chain \nTCL 2023 will provide a deep-dive into what these industry developments mean for Pharmaceutical Logistics\, Quality Assurance & Supply Chain practitioners and focus on delivering a mix of interactive sessions\, which will enable delegates to leverage the collective knowledge of their peers and brainstorm solutions to the challenges\, which the industry is facing. \nTCL doesn’t just stand for Temperature Control and Logistics\, now it also stands for Transformation\, Collaboration and Learning! >> Download the full agenda to view full speaker line-up\, discussion details\, sponsorship opportunities\, and more!
URL:https://www.pharmajournalist.com/event/temperature-control-and-logistics-summit/
LOCATION:Sheraton Frankfurt Airport Hotel & Conference Center\, Hugo-Eckener-Ring 15/Terminal 1\, Frankfurt am Main\, 60549\, Germany
ORGANIZER;CN="IQPC Limited":MAILTO:enquire@iqpc.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230613
DTEND;VALUE=DATE:20230616
DTSTAMP:20260516T063430
CREATED:20230503T050638Z
LAST-MODIFIED:20230503T050638Z
UID:37123-1686614400-1686873599@www.pharmajournalist.com
SUMMARY:3rd ILD Summit
DESCRIPTION:Returning for the 3rd year\, the ILD Summit will lean into the industry’s key challenges\, explore pipeline opportunity development\, and look towards the future for ILD therapeutic development from idiopathic pulmonary fibrosis pipelines. From illuminating predictors of progression to define and identify the progressive fibrosis phenotypes for patient stratification to evolving clinical trial design with novel secondary and exploratory endpoints beyond FVC. This is a fantastic point in 2023 for the lung fibrosis community to come together to meet at the intersection of pulmonology and rheumatology to advance therapeutic development for ILDs. \nTo know more visit: https://ter.li/wc2uto
URL:https://www.pharmajournalist.com/event/3rd-ild-summit/
LOCATION:The Colonnade Hotel\, 120 Huntington Ave\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR